University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Preclinical Evaluation of [18F]LCATD as a PET Tracer to Study Drug-Drug Interactions Caused by Inhibition of Hepatic Transporters

Simple item page
dc.contributor.authorTesta, Andrea
dc.contributor.authorDall'Angelo, Sergio
dc.contributor.authorMingarelli, Marco
dc.contributor.authorAugello, Andrea
dc.contributor.authorSchweiger, Lutz
dc.contributor.authorWelch, Andrew
dc.contributor.authorElmore, Charles S
dc.contributor.authorDawson, Dana
dc.contributor.authorSharma, Pradeep
dc.contributor.authorZanda, Matteo
dc.contributor.institutionUniversity of Aberdeen.Kosterlitz Centre for Therapeuticsen
dc.contributor.institutionUniversity of Aberdeen.Medicine, Medical Sciences & Nutritionen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.contributor.institutionUniversity of Aberdeen.Energyen
dc.contributor.institutionUniversity of Aberdeen.Medical Educationen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Biomedical Imaging Centreen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciences - Cardiovascular Groupen
dc.date.accessioned2018-08-08T15:07:07Z
dc.date.available2018-08-08T15:07:07Z
dc.date.issued2018-07-30
dc.descriptionAcknowledgements: A.T. gratefully acknowledges SINAPSE (www.sinapse.ac.uk) and AstraZeneca (UK) for co-funding a studentship. P.S. and C.S.E. are employees of AstraZeneca Ltd., UK. This project has also received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 675417.en
dc.description.statusPeer revieweden
dc.format.extent10
dc.format.extent3129054
dc.identifier119483936
dc.identifierf8a479c9-52dc-46d2-b391-3a824f65aabe
dc.identifier30154685
dc.identifier85051518403
dc.identifier.citationTesta, A, Dall'Angelo, S, Mingarelli, M, Augello, A, Schweiger, L, Welch, A, Elmore, C S, Dawson, D, Sharma, P & Zanda, M 2018, 'Preclinical Evaluation of [ 18 F]LCATD as a PET Tracer to Study Drug-Drug Interactions Caused by Inhibition of Hepatic Transporters', Contrast Media & Molecular Imaging, vol. 2018, 3064751. https://doi.org/10.1155/2018/3064751en
dc.identifier.doi10.1155/2018/3064751
dc.identifier.issn1555-4317
dc.identifier.otherPubMedCentral: PMC6091370
dc.identifier.otherORCID: /0000-0003-2815-4469/work/160846715
dc.identifier.otherORCID: /0000-0001-9377-0474/work/176747531
dc.identifier.urihttp://hdl.handle.net/2164/10875
dc.language.isoeng
dc.relation.ispartofContrast Media & Molecular Imagingen
dc.subjectR Medicine (General)en
dc.subjectEuropean Commissionen
dc.subject675417en
dc.subject.lccR1en
dc.titlePreclinical Evaluation of [18F]LCATD as a PET Tracer to Study Drug-Drug Interactions Caused by Inhibition of Hepatic Transportersen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Preclinical_Evaluation_of_18F_LCATD_as_a_PET_Tracer_to.pdf
Size:
2.98 MB
Format:
Adobe Portable Document Format
Download

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
8.29 KB
Format:
Plain Text
Description:
Download

Collections

All research
Applied Medicine research
Medical & Dental Education research
Medical Sciences research
University Office research